glp 1 agonist review article GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art Glucagon‐like peptide agonists: A prospective

Genetics and receptor sensitivity Individual variation in GLP-1 receptor expression, density, and sensitivity creates a genetic component to treatment response

Scale that up: by 2031, this could mean 60 to 90 billion dollars less spent annually on food in the US alone. For the processed food industry, this is a nightmare

Bozorgi, A., Khazaei, M

Zeng N, Cutts EJ, Lopez CB, Kaur S, Duran M, Virkus SA, et al

While healthy fibroblasts maintain healthy tissue structure, pro-fibrotic fibroblasts support fibrosis

GLP-1 has become a major focus in diabetes treatment and weight management because of its natural ability to control glucose levels and promote satiety